Biomark Diagnostics Inc. (CSE:BUX)
0.4750
-0.0050 (-1.04%)
At close: Dec 5, 2025
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of CAD 46.44 million as of December 5, 2025. Its market cap has increased by 200.17% in one year.
Market Cap
46.44M
Enterprise Value
45.70M
Revenue
123.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.48
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 40.39M to 46.44M, an increase of 14.99%. That is a compound annual growth rate of 1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 46.44M | 213.96% |
| Dec 30, 2024 | 14.79M | -17.24% |
| Dec 29, 2023 | 17.87M | 24.67% |
| Dec 30, 2022 | 14.34M | -23.96% |
| Dec 30, 2021 | 18.85M | 116.77% |
| Dec 30, 2020 | 8.70M | -51.10% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.93B |
| Green Thumb Industries | 2.22B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.91B |
| Extendicare | 1.85B |
| Trulieve Cannabis | 1.48B |
| Cronos Group | 1.34B |
| WELL Health Technologies | 1.01B |